157 related articles for article (PubMed ID: 24824848)
21. Molecular basis of FIR-mediated c-myc transcriptional control.
Cukier CD; Hollingworth D; Martin SR; Kelly G; Díaz-Moreno I; Ramos A
Nat Struct Mol Biol; 2010 Sep; 17(9):1058-64. PubMed ID: 20711187
[TBL] [Abstract][Full Text] [Related]
22. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
[TBL] [Abstract][Full Text] [Related]
23. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.
Liu J; Kouzine F; Nie Z; Chung HJ; Elisha-Feil Z; Weber A; Zhao K; Levens D
EMBO J; 2006 May; 25(10):2119-30. PubMed ID: 16628215
[TBL] [Abstract][Full Text] [Related]
24. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma.
Rousseau B; Ménard L; Haurie V; Taras D; Blanc JF; Moreau-Gaudry F; Metzler P; Hugues M; Boyault S; Lemière S; Canron X; Costet P; Cole M; Balabaud C; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J
Hepatology; 2007 Oct; 46(4):1108-18. PubMed ID: 17657734
[TBL] [Abstract][Full Text] [Related]
25. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K
Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183
[TBL] [Abstract][Full Text] [Related]
26. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth.
Rabenhorst U; Beinoraviciute-Kellner R; Brezniceanu ML; Joos S; Devens F; Lichter P; Rieker RJ; Trojan J; Chung HJ; Levens DL; Zörnig M
Hepatology; 2009 Oct; 50(4):1121-9. PubMed ID: 19637194
[TBL] [Abstract][Full Text] [Related]
28. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma.
Lee NP; Tsang FH; Shek FH; Mao M; Dai H; Zhang C; Dong S; Guan XY; Poon RT; Luk JM
Int J Cancer; 2010 Aug; 127(4):968-76. PubMed ID: 19998337
[TBL] [Abstract][Full Text] [Related]
30. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2.
Wang F; Yuan JH; Wang SB; Yang F; Yuan SX; Ye C; Yang N; Zhou WP; Li WL; Li W; Sun SH
Hepatology; 2014 Oct; 60(4):1278-90. PubMed ID: 25043274
[TBL] [Abstract][Full Text] [Related]
31. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
[TBL] [Abstract][Full Text] [Related]
32. Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase.
Chuma M; Sakamoto N; Nakai A; Hige S; Nakanishi M; Natsuizaka M; Suda G; Sho T; Hatanaka K; Matsuno Y; Yokoo H; Kamiyama T; Taketomi A; Fujii G; Tashiro K; Hikiba Y; Fujimoto M; Asaka M; Maeda S
Carcinogenesis; 2014 Feb; 35(2):272-81. PubMed ID: 24130164
[TBL] [Abstract][Full Text] [Related]
33. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
34. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
35. Lentiviral-mediated short hairpin RNA silencing of APE1 suppresses hepatocellular carcinoma proliferation and migration: A potential therapeutic target for hepatoma treatment.
Zheng ZH; Du W; Li YJ; Gao MQ; Huang AM; Liu JF
Oncol Rep; 2015 Jul; 34(1):95-102. PubMed ID: 25976295
[TBL] [Abstract][Full Text] [Related]
36. Nuclear accumulation of seven in absentia homologue-2 supports motility and proliferation of liver cancer cells.
Malz M; Aulmann A; Samarin J; Bissinger M; Longerich T; Schmitt S; Schirmacher P; Breuhahn K
Int J Cancer; 2012 Nov; 131(9):2016-26. PubMed ID: 22323152
[TBL] [Abstract][Full Text] [Related]
37. In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence.
Ménard L; Taras D; Grigoletto A; Haurie V; Nicou A; Dugot-Senant N; Costet P; Rousseau B; Rosenbaum J
J Hepatol; 2010 May; 52(5):681-9. PubMed ID: 20346530
[TBL] [Abstract][Full Text] [Related]
38. Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.
Crichlow GV; Zhou H; Hsiao HH; Frederick KB; Debrosse M; Yang Y; Folta-Stogniew EJ; Chung HJ; Fan C; De la Cruz EM; Levens D; Lolis E; Braddock D
EMBO J; 2008 Jan; 27(1):277-89. PubMed ID: 18059478
[TBL] [Abstract][Full Text] [Related]
39. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.
Chen Y; Lin MC; Yao H; Wang H; Zhang AQ; Yu J; Hui CK; Lau GK; He ML; Sung J; Kung HF
Hepatology; 2007 Jul; 46(1):200-8. PubMed ID: 17596871
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
Chang RM; Yang H; Fang F; Xu JF; Yang LY
Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
